🔎 Trials Near Me

Home › Atherosclerosis › NCT04505865

The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease

Recruiting

The Effect of Mindfulness on Vascular Inflammation in Stable Coronary Disease: A Multi-System PET/MRI Study

Who can join

Ages 45 to 65 · All sexes

Full eligibility criteria
Inclusion Criteria:

* Must admit to feeling stressed and/or have PSS score \> 13 (moderate stress)
* Must be willing to complete stress reduction course and imaging sessions with \< 3 missed appointments in last year
* Known clinical cardiovascular disease with prior atherosclerotic myocardial infarction, percutaneous intervention or bypass surgery \> 6 months before entry, or severe coronary calcifications on computed tomography or coronary calcium score \>400
* Stable symptoms without symptomatic heart failure or arrhythmia or planned revascularization
* Maximally tolerated and stable medical regimen for 90 days that does not include a high intensity statin for clinical reasons
* No neurological disease or systemic inflammatory disease/current anti-inflammatory therapy
* No active psychiatric disease/medications or substance abuse (including tobacco smoking or more than moderate alcohol) for last 6 months
* No current participation in cardiac rehab or prior participation in stress reduction
* For imaging: no pregnancy, weight \> 300 lbs., metal implants, uncontrolled hyperglycemia, or inability to provide consent or comply

About the study

This study aims to evaluate the effect of 8 weeks of a stress reduction intervention on atherosclerotic plaque inflammation in adults with stable coronary artery disease, as quantified by positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in individuals with increased psychosocial stress.

What is being tested

Sponsor: Massachusetts General Hospital · Participants: 36 · Started: Nov 1, 2021

Contact the study team

Official record on ClinicalTrials.gov — NCT04505865

Locations in the U.S.

MassachusettsMassachusetts General Hospital, Boston

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.